1World Health Organization (2011) Global Atlas on Cardiovascular Disease Prevention and Control. Geneva: WHO.
2World Health Organization (2007) Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Cardiovascular Risk. Geneva: WHO.
3World Health Organization (2009) Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: WHO.
4Manson, JE, Tosteson, H, Ridker, PM, et al. (1992) The primary prevention of myocardial infarction. N Engl J Med 326, 1406–1416.
5Schuster, H (2004) Improving lipid management: to titrate, combine, or switch. Int J Clin Pract 58, 689–694.
6Talbert, RL (2002) New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III. Am J Manag Care 8, S301–S307.
7Reid, G, Jass, J, Sebulsky, MT, et al. (2003) Potential uses of probiotics in clinical practice. Clin Microbiol Rev 4, 658–672.
8Marteau, P (2001) Safety aspects of probiotic products. Scand J Nutr 45, 22–24.
9Chettipalli, ND, Santosh, P & Raj, P (2011) Evaluation of the various uses of microorganisms with emphasis on probiotics. J Microbial Biochem Technol R1, 004.
10Gilliland, SE, Nelson, CR & Maxwell, C (1985) Assimilation of cholesterol by Lactobacillus acidophilus. Appl Environ Microbiol 49, 377–381.
11Danielson, AD, Peo, ER, Shahani, KM, et al. (1989) Anticholesterolemic property of Lactobacillus acidophilus yoghurt fed to mature boars. J Anim Sci 67, 966–974.
12De Smet, I, De Boever, P & Versteaete, W (1998) Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity. Br J Nutr 79, 185–194.
13Liong, MT & Shah, NP (2005) Bile salt deconjugation ability, bile salt hydrolase activity and cholesterol co-precipitation ability of lactobacilli strains. Int Dairy J 15, 391–398.
14Bosch, M, Rodriguez, M, Garcia, F, et al. (2012) Probiotic properties of Lactobacillus plantarum CECT7315 and CECT7316 isolated from faeces of healthy children. Lett Appl Microbiol 54, 240–246.
15Kishida, T, Nogami, H, Ogawa, H, et al. (2002) The hypocholesterolemic effect of high amylose cornstarch in rats is mediated by an enlarged bile acid pool and increased fecal bile acid excretion, not by cecal fermented products. J Nutr 132, 2519–2524.
16Jones, ML, Martoni, CJ, Parent, M, et al. (2011) Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br J Nutr 107, 1505–1513.
17Bertolami, MC, Faludi, AA & Batlouni, M (1999) Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia. Eur J Clin Nutr 53, 97–101.
18Holvoet, P, Lee, DH, Steffes, M, et al. (2008) Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 299, 2287–2293.
19Hou, R & Goldberg, AC (2009) Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety. Endocrinol Metab Clin North Am 38, 79–97.
20Agerbaek, M, Gerdes, LU & Richelsen, B (1995) Hypocholesterolemic effect of a new fermented milk product in healthy middle-aged men. Eur J Clin Nutr 49, 346–352.
21Pereira, DI & Gibson, GR (2002) Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 37, 259–281.
22Wollowski, I, Rechkemmer, G & Pool-Zobel, BL (2001) Protective role of probiotics and prebiotics in colon caner. Am J Clin Nutr 73, S451–S455.
23Begley, M, Hill, C & Gahan, CG (2006) Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 72, 1729–1738.
24Bays, HE, Davidson, M, Jones, MR, et al. (2006) Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia. Am J Cardiol 97, 1198–1205.
25Ling, WH & Jones, PJH (1995) Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci 57, 196–206.
26Ostlund, RE & Matthews, DE (1993) [13C]cholesterol as a tracer for studies of cholesterol metabolism in humans. J Lipid Res 34, 1825–1831.
27European Food Safety Authority (2007) Opinion of the scientific panel on dietetic products, nutrition and allergies on a request from the commission related to a notification from Cognis, DM and Cargill on vegetable oils-derived phytosterols and phytosterol esters from soybean sources pursuant to article 6 paragraph 11 of directive 2000/13/EC. EFSA J 486, 1–8.